Adagene
ADAG
13 hedge funds and large institutions have $25.3M invested in Adagene in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.12% less ownership
Funds ownership: 20.33% → 20.21% (-0.12%)
7% less funds holding
Funds holding: 14 → 13 (-1)
25% less capital invested
Capital invested by funds: $33.7M → $25.3M (-$8.39M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Exome Asset Management
New York
|
+$294K |
| 2 |
MCCA
Mill Creek Capital Advisors
Conshohocken,
Pennsylvania
|
+$239K |
| 3 |
Morgan Stanley
New York
|
+$5.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$595K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$106K |
| 3 |
CCG
Catalina Capital Group
Torrance,
California
|
-$10.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$502 |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$144 |
ADAG Hedge Fund Activity: Q3 2024 in Review
13 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Adagene (ADAG) for Q3 2024, worth a combined $25.3M — down 25% from $33.7M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ADAG and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Exome Asset Management, adding an estimated $294K. The largest seller was Fidelity International, cutting an estimated $595K.
- 13 institutional investors held Adagene (ADAG) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $25.3M of Adagene stock for Q3 2024, down 25% quarter-over-quarter.
- 1 fund opened new Adagene positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Adagene buyer in Q3 2024 was Exome Asset Management, an estimated $294K added.
- The largest Adagene seller in Q3 2024 was Fidelity International, an estimated $595K sold.
Based on aggregated 13F filings for Q3 2024.